Dermoscribe Ichybum Cream
NDC Package 69683-101-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dermoscribe Ichybum (hydrocortisone, clioquinol, zinc oxide) cream is dERMOSCRIBE'S ICHYBUM ANAL ITCHING CREAM IS A TOPICAL TREATMENT FOR RELIEF OF THE SYMPTOMS OF PRURITUS ANI AND OTHER AFFLICTIONS INVOLVING CHRONIC ITCHING AROUND THE ANUS. This formulation utilizes a cream delivery system. Marketed by Dermoscribe Pty Ltd, this product is identified by NDC 69683-101 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
69683-101-11
Package Description
28 g in 1 BOTTLE
Product Code
69683-101
11-Digit Billing Format
69683010111
RxNorm Crosswalk
  • RxCUI: 1606483 - hydrocortisone 1 % / clioquinol 1 % Rectal Cream
  • RxCUI: 1606483 - clioquinol 10 MG/ML / hydrocortisone 10 MG/ML Rectal Cream

Clinical Specifications

Proprietary Name
Dermoscribe Ichybum
Non-Proprietary Name
Hydrocortisone, Clioquinol, Zinc Oxide
Substance Name
Clioquinol; Hydrocortisone
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
DERMOSCRIBE'S ICHYBUM ANAL ITCHING CREAM IS A TOPICAL TREATMENT FOR RELIEF OF THE SYMPTOMS OF PRURITUS ANI AND OTHER AFFLICTIONS INVOLVING CHRONIC ITCHING AROUND THE ANUS.

Regulatory & Marketing

Labeler Name
Dermoscribe Pty Ltd
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-23-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69683-101-11 identifies a specific commercial package of 28 g in 1 bottle of Dermoscribe Ichybum, a human over the counter drug labeled by Dermoscribe Pty Ltd. This cream is formulated for topical use and contains clioquinol; hydrocortisone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dermoscribe Pty Ltd on March 23, 2015. The current certification is valid through December 31, 2026.

How is this Dermoscribe Pty Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69683010111. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69683-101-11
11-Digit CMS (5-4-2)
69683-0101-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.